XWELL, Inc. (XWEL): Nasdaq/NYSE listing notice — XWELL granted 180-day extension by Nasdaq to regain minimum bid price compliance

XWELL, Inc.

Nasdaq extended cure period to October 23, 2023 for bid price below $1.00.
To regain compliance, closing bid price must be ≥ $1.00 for 10 consecutive business days.
Company intends to consider a reverse stock split if needed to meet the requirement.
No immediate impact on listing or trading of XWEL common stock on Nasdaq Capital Market.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

XWELL, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

April 27, 2023, the Company received an extension of 180 calendar days from Nasdaq to regain compliance with the Bid Price Requirement, following the expiration of the initial 180 calendar days period to regain compliance. According to the notification from Nasdaq, the determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the Bid Price Requirement, and the Company’s written notice of its intention to cure the deficiency

View on SEC.gov

16 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

XWELL, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-051380

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.